Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Other financing activities (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Other financing activities data on record, last reported at $27000.0 in Q2 2024.

  • For Q2 2024, Other financing activities fell 97.03% year-over-year to $27000.0; the TTM value through Dec 2024 reached $1.0 million, changed N/A, while the annual FY2024 figure was $1.0 million, 70.3% down from the prior year.
  • Other financing activities reached $27000.0 in Q2 2024 per SGMT's latest filing, down from $1.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $1.0 million in Q1 2024 and bottomed at $27000.0 in Q2 2024.